Skip to content

Clinical trials

Phase 2/3 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2/3 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20052
20061
20071
20091
20111
20122
20143
20152
20161
20172
20183
20202
20211
20221
20231
20246
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting9
Unknown status7
Terminated5
Active, not recruiting4
Not yet recruiting3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong2
Fudan University2
Tianjin Medical University Cancer Institute and Hospital2
1Globe Health Institute LLC1
Alliance for Clinical Trials in Oncology1
Assistance Publique - Hôpitaux de Paris1
Assiut University1
Astex Pharmaceuticals, Inc.1
Auron Healthcare GmbH1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms41
Neoplasm Metastasis5
Neoplasms5
Colonic Neoplasms3
Colorectal Neoplasms3
Gallbladder Neoplasms3
Lung Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Carcinoma, Hepatocellular2

Trials

Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.